Home Page: Radiotherapy and Oncology

Skip to Main Content

Articles in Press

Original Article
Prognostic radiomic signature for head and neck cancer: development and validation on a multi-centric MRI dataset
Published online: March 31, 2023
Original Article
Open Access
Advances in radiotherapy and its impact on second primary cancer risk: a multi-center cohort study in prostate cancer patients
Published online: March 30, 2023
Protocol Letter
Protocol letter: Intra-treatment Image Guided Adaptive Radiotherapy Dose-escalation Study (InGReS) - a Phase 1 multicentre feasibility study
Published online: March 28, 2023
Original Article
Comparison of supraclavicular surgery plus radiotherapy versus radiotherapy alone in breast cancer patients with synchronous ipsilateral supraclavicular lymph node metastasis: a multicenter retrospective study
Published online: March 27, 2023

Issue Highlights

Editorial board
Aims+Scope/Editorial Board/Publication information
Published in issue: March, 2023
Research Article
Open Access
Tumor volume definitions in head and neck squamous cell carcinoma – Comparing PET/MRI and histopathology
Published online: January 20, 2023
Original Article
Open Access
Survival benefit of radiotherapy following narrow-margin hepatectomy in patients with hepatocellular carcinoma: A propensity score-matched analysis based on phase II study
Published online: January 9, 2023
Original Article
Open Access
Validation of the ¹⁸F-FDG PET image biomarker model predicting late xerostomia after head and neck cancer radiotherapy
Published online: January 3, 2023

About

Cover Image - Radiotherapy and Oncology, Volume 180, Issue

Radiotherapy & Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as physical aspects relevant to oncology, particularly in the field of imaging, dosimetry and radiation therapy planning. More

Founded in 1980, ESTRO, the European SocieTy for Radiotherapy & Oncology, is a non-profit and scientific organisation that fosters the role of Radiation Oncology in order to improve patients’ care in the multimodality treatment of cancer.

With over 6,500 members inside and outside Europe, ESTRO supports all the Radiation Oncology professionals in their daily practice: Radiation Oncologists, Medical Physicists, Radiobiologists and RTTs (Radiation TherapisTs) and the wider oncology community.

ESTRO’s mission is to promote innovation, research, and dissemination of science through its congresses, special meetings, educational courses and publications.

Metrics

Most Read (Last 30 Days)

Original Article
Open Access
First-in-human technique translation of oxygen-enhanced MRI to an MR Linac system in patients with head and neck cancer
Published online: March 2, 2023
Guidelines
Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines
Published online: November 4, 2013
Original Article
Open Access
ESTRO ACROP guideline for target volume delineation of skull base tumors
Published online: December 9, 2020
Original Article
Open Access
Chemoradiation for muscle-invasive bladder cancer using 5-fluorouracil versus capecitabine: A nationwide cohort study
Published online: February 28, 2023
Original Article
Open Access
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus
Published online: October 10, 2022
Original Article
Open Access
IBS-GEC ESTRO-ABS recommendations for CT based contouring in image guided adaptive brachytherapy for cervical cancer
Published online: May 17, 2021

Most Cited (Previous 3 Years)

The content on this site is intended for healthcare professionals.

Copyright © 2023 Elsevier Inc. except certain content provided by third parties.

RELX